Aflo Analytics key facts
as of Oct 2026- Developer of a healthcare technology designed to provide information related to how to inhale medicines correctly.
- Aflo Analytics is valued at approximately $2.5M as of Oct 2026 (last reported valuation).
- It has raised $430K; the latest was Later Stage VC in Mar 2025.
- Notable investors include Innovate UK, Techstart Ventures, Clarendon Fund Managers, Invest Northern Ireland, Duncreggan Student Village — 8 tracked in total.
- Status: Privately Held (backing).
Aflo Analytics's last reported valuation, Jan 2021. Nothing priced has surfaced since.
- ·Watch Aflo Analytics: the Monday email on marks, rounds and moves
Aflo Analytics funding rounds
No funding rounds for Aflo Analytics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Aflo Analytics valuation
Aflo Analytics's last reported valuation was $2.5 million in Jan 2021. No priced round, secondary trade or fund mark has surfaced since.
Aflo Analytics investors
8 investors are on record for Aflo Analytics, including Innovate UK, Techstart Ventures, Clarendon Fund Managers and Invest Northern Ireland.
About Aflo Analytics
Developer of a healthcare technology designed to provide information related to how to inhale medicines correctly. The company's technology leverages AI, sensors, and hyper-personalized data to get the medication deep into the lungs and aggregate the inhalation data with air quality, enabling the medical community and patients to improve asthma, COPD, and cystic fibrosis outcomes, as well as viral data to help identify asthma attack triggers.
- Sector
- Healthcare
- HQ
- Londonderry, United Kingdom
- Founded
- 2019
- Employees
- 2
- Website
- afloanalytics.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.